The drug retention for SEC and TNFi was similar in this RW study of 279 patients (TNFi 178, SEC 101).In subgroups analyses, age, BASDAI at diagnosis and BMI did not favour any group @RheumNow #ACR21 Abst#0911 https://t.co/g1tIy1qMX1 https://t.co/LHZMxMlzIB
Links:
Drug Retention of Tumor Necrosis Factors and IL-17 Inhibitors in Axial Spondylo…
https://bit.ly/3kgSzEu
07-11-2021
